Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Neuroendocrine prostate cancers are very difficult to treat and often arise after androgen-deprivation therapy. Here the authors show that ADT activates CREB that acts by increasing EZH2 activity to promote neuroendocrine differentiation in prostate cancer, providing alternative avenues for therapy.
Guardado en:
Autores principales: | Yan Zhang, Dayong Zheng, Ting Zhou, Haiping Song, Mohit Hulsurkar, Ning Su, Ying Liu, Zheng Wang, Long Shao, Michael Ittmann, Martin Gleave, Huanxing Han, Feng Xu, Wangjun Liao, Hongbo Wang, Wenliang Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25a7d86d01c14730b94ebc63e65d2641 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine
por: Elham Barazeghi, et al.
Publicado: (2021) -
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
por: Dominick G A Burton, et al.
Publicado: (2013) -
Metabolic changes in patients with prostate cancer with androgen deprivation therapy
por: Maxim N. Peshkov, et al.
Publicado: (2020) -
TETRAHEURÍSTICA SISTÉMICA (THS) PARA EL TSP
por: Pérez Rave,Jorge Iván, et al.
Publicado: (2010) -
Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
por: Renee Brady-Nicholls, et al.
Publicado: (2020)